"对于人类来说这个动作非常简单、非常直接，但是对于机器人来讲，后面是一套极其复杂的人工智能 算法在支撑。"徐科说，希望这样一个人形机器人不仅仅能够做到抓起苹果这件简单的事情，更希望它 是一个有温度的人类助手——比如它能听懂家里老人的方言指令，能辅导小朋友的课业，甚至能陪下一 盘棋或者打一局游戏。 四川省政协委员建言"人形机器人如何走进寻常百姓家" 中新网成都2月2日电 (记者 岳依桐)四川省政协十三届四次会议"委员通道"集体采访活动第一场2月2日 上午在成都举行。深耕人工智能研究十余年的四川省政协委员、中兴微电子人工智能首席科学家徐科 就"人形机器人如何走进寻常百姓家"进行解读并发表自己的观点。 "我想和大家分享一个有趣的现象。这几年人工智能，尤其是大模型整天忙着写诗和作画，帮我们搞创 作。但是我们每天回家之后，却依然要洗衣做饭、打扫卫生。"徐科幽默开场，"所以我认为人形机器人 的价值，恰恰藏在这样一种错位里面——只有机器人帮助我们处理日常琐事，我们每天回家才有时间和 心情写诗和画画，甚至唱歌跳舞。" 随即，他又分享了一个小故事：人形机器人Figure站在桌前，桌上依次摆放了一瓶水、一个枕头和一个 苹果。这时 ...

Core Viewpoint - The strategic partnership between Eli Lilly, a leading pharmaceutical company, and Nvidia, a top technology giant, marks a significant shift in the pharmaceutical industry, focusing on AI-driven drug development and manufacturing processes [1][14]. Group 1: Partnership Details - Eli Lilly and Nvidia will invest $1 billion over five years to establish a joint innovation lab in the San Francisco Bay Area [1]. - The lab will not only serve as a computing center but will also aim to completely restructure the drug development process using AI [2]. - The partnership will utilize Nvidia's latest AI chip architecture, Vera Rubin, which is designed for high-precision scientific calculations essential for drug development [2][3]. Group 2: Technological Integration - The collaboration will integrate hardware and software, with Nvidia's BioNeMo platform and Eli Lilly's TuneLab platform combining to enhance drug discovery [3][4]. - BioNeMo will function as a generative AI platform for biology, capable of generating new protein structures, while Eli Lilly will contribute its extensive historical experimental data [3][4]. - The partnership aims to address the data and model gap in AI healthcare, leveraging federated learning technology [4]. Group 3: Manufacturing Innovations - The collaboration extends to manufacturing, with plans to create a "digital twin" of Eli Lilly's production line using Nvidia's Omniverse platform [5]. - This digital twin will simulate production processes to optimize supply chain efficiency, potentially leading to significant revenue increases for high-demand products [5]. Group 4: Industry Context and Implications - Eli Lilly's decision to partner with Nvidia reflects a strategic move to overcome the challenges of traditional drug development, which is often time-consuming and costly [6][7]. - The partnership signifies a shift from a "Discovery" to a "Design" paradigm in drug development, allowing for targeted molecular design rather than random screening [7][8]. - The collaboration is expected to accelerate industry changes, prompting other major pharmaceutical companies to seek similar technological partnerships [16][18]. Group 5: Future Outlook - The partnership is seen as a potential turning point in AI-driven pharmaceutical development, creating a new model of collaboration between top pharmaceutical and technology companies [15][16]. - The competition in the pharmaceutical industry is likely to intensify as companies race to secure technological alliances, with AI becoming a critical component of drug development [19][20].

Core Insights - The discovery of a super-Earth, Kepler-725c, in the habitable zone of a sun-like star, Kepler-725, represents a significant breakthrough in the search for extraterrestrial life [1][3] - The research was led by the Yunnan Observatory of the Chinese Academy of Sciences and utilized Transit Timing Variation (TTV) technology [1][4] - The findings were published in the prestigious journal Nature Astronomy, highlighting the potential for discovering Earth-like planets [1] Group 1 - The super-Earth Kepler-725c has a mass approximately 10 times that of Earth and is located in the habitable zone, which is crucial for the existence of liquid water [1][3] - Kepler-725, the host star, is a G9V type, younger than the Sun at 1.6 billion years old, and exhibits more intense magnetic activity [3][4] - The orbital period of Kepler-725c is about 207.5 days, which is similar to Earth's orbital period, suggesting potential similarities in environmental conditions [3] Group 2 - The discovery opens new avenues for finding "Earth 2.0" in the habitable zones of sun-like stars, which is essential for understanding the origins of life [1][4] - The distance from Earth to Kepler-725c is approximately 160 million kilometers, which is a significant distance in astronomical terms [4]

我今天已经不发烧了，这次没有流鼻涕咳嗽等症状，就是肚子吃坏了，腹泻很严重，一天要上七八次洗手间，从固体拉到液体，搞得我现 在放p都不敢坐在凳子上，我怕什么你们肯定懂的。已经吃了蒙脱石散，还买了一打的外星人电解质水补充，总的来说不碍事了。 未来人类想要走出太阳系，这副碳基的皮囊就是最大的短板，怕冷、怕热、气压低了高了都不行，必须刚刚好，每天需要摄入水和食物， 还要排泄，必须保持一定量运动维持健康，否则容易生病（生理+心理），理论寿命不超过150岁，在宇宙尺度而言这太短暂了。 进化了几亿年也就这水平，其它星系的生命估计也好不到哪去。所以宇宙就是一个又一个独立的孤岛，或者说监狱，文明和文明之间谁也 遇不到谁。有人可能觉得，我的想象力不够丰富，别的星系的生命也许是我想象不到的形式呢？ 可能性很小。我们由碳基形成生命不是一个巧合，而是这个物理规则的宇宙下，碳的分子结构和稳定性决定了它就是最适合的生命分子， 其它可能性也有，比如硅基、氨基、铁基，也有可能形成生命，但对环境的要求很苛刻，很不稳定。从星际航行的角度而言，这些生命体 的适应性还不如碳基，所以更没戏。 我假想过其它星球的生命，外形可能千奇百怪，但底层分子大概率和 ...